Clinical Trials for Prinicipal Investigator: Samuel Ejadi

2 Open Trials. Phone:(877.827.8839)
Protocol No. Title Status
UCI-15-74 An Open-Label, Multicenter, Global Phase 2 Basket Study of Entrectinib for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors that Harbor NTRK1/2/3, ROS1, or ALK Gene Rearrangements Open
UCI-17-33 A Randomized Phase 2 Trial of Neoadjuvant and Adjuvant Therapy with the IRX-2 Regimen in Patients with Newly Diagnosed Stage II, III or IVA Squamous Cell Carcinoma of the Oral Cavity. Open